Home › Funds › Renaissance Technologies › STRO
Renaissance Technologies position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q2 2026)86.32K sh
Reported value held$2.87M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 48.70K | $725.00K | New |
| Q2 2022 | 147.70K | $770.00K | New |
| Q3 2022 | 215.90K | $1.20M | Add |
| Q4 2022 | 29.90K | $242 | Reduce |
| Q1 2023 | 129.40K | $598 | Add |
| Q2 2023 | 269.50K | $1.25K | Add |
| Q3 2023 | 302.90K | $1.05K | Add |
| Q4 2023 | 655.80K | $2.81K | Add |
| Q1 2024 | 485.80K | $2.75K | Reduce |
| Q2 2024 | 719.50K | $2.11M | Add |
| Q3 2024 | 828.10K | $2.87M | Add |
| Q4 2024 | 1.02M | $1.87M | Add |
| Q1 2025 | 869.00K | $565.37K | Reduce |
| Q2 2025 | 913.20K | $651.93K | Add |
| Q3 2025 | 1.42M | $1.24M | Add |
| Q4 2025 | 122.86K | $1.42M | Reduce |
| Q1 2026 | 97.82K | $2.44M | Reduce |
| Q2 2026 | 86.32K | $2.87M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- BlackRock Inc 1.12M sh · $37.27M · Q2 2026
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Geode Capital Management 389.69K sh · $12.94M · Q2 2026
- Millennium Management 365.97K sh · $12.15M · Q2 2026
- Point72 Asset Management 237.83K sh · $7.90M · Q2 2026
- UBS Group AG 208.51K sh · $6.92M · Q2 2026
- Two Sigma Investments 201.69K sh · $6.70M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026